Group   Baseline   Week 16   Group X time effects*
1RM-sum of 8 lifts, kg UBR-Combined
CE+HE
290 ± 98
313 ± 78
 409 ± 149
350 ± 90
P < 0.001
Whole body fat, % UBR-Combined
CE+HE
30.3 ± 7.1
29.3 ± 7.4
29.6 ± 7.3
29.5 ± 7.4
P = 0.024
Lean arm mass, kg UBR-Combined
CE+HE
6.1 ± 1.8
6.1 ± 1.1
6.4 ± 1.9
6.1 ± 1.2
P = 0.003
PImax, cm H2O UBR-Combined
CE+HE
76.6 ± 26.2
75.6 ± 23.6
75.7 ± 25.8
71.5 ± 24.8
P = 0.166
CRQ Dyspnea, scale score UBR-Combined
CE+HE
4.1 ± 1.0
4.2 ± 1.1
4.6 ±1.2
4.2 ± 1.1
P = 0.053
CRQ Fatigue, scale score UBR-Combined
CE+HE
4.2 ± 1.1
4.4 ± 1.0
4.8 ± 1.2
4.9 ± 1.0
P = 0.145
UB-FPT, laps UBR-Combined
CE+HE
7.1 ± 1.6
6.8 ± 2.1
7.2 ±1.7
7.2 ± 2.0
P = 0.194
FPI, total score UBR-Combined
CE+HE
2.1 ± 0.4
2.1 ± 0.5
2.2 ± 0.5
2.2 ± 0.5
P = 0.316
SE-Upper Body Resistance Training, total score UBR-Combined
CE+HE
49 ± 21
49 ± 22
75 ±18
53 ± 23
P < 0.001
SE-Upper Body Physical Activity, total score UBR-Combined
CE+HE
58 ± 18
58 ± 25
66 ± 20
60 ± 23
P = 0.054
BE-COPD, total score UBR-Combined
CE+HE
75 ±18
77 ± 18
75 ± 22
70 ± 26
P = 0.137
Data are mean ± SD.
*Abbreviations: BE-COPD: Barriers Efficacy COPD Version; FPI: Functional Performance Inventory; PIMAX: Maximal Inspiratory Pressure; SE-Upper-Body Exercise: Self-Efficacy for Upper-Body Exercise; SE-Upper Body Physical Activity: Self-Efficacy for Upper-Body Physical Activity; UB-FPT: Upper-Body Functional Performance Test MANOVA between-subjects: Group F(1,62) = 0.739, P = 0.697; gender F(1,62) = 8.707, P < 0.001; FEV1 % predicted F(1,62) = 3.664, P = 0.001.
MANOVA within-subjects effects: time F(1,62) = 0.709, P = 0.724; interaction of time by group assignment F(1,62) = 3.720, P = 0.001; interaction of time by gender F(1,62)=1.165, P = 0.335; interaction of time by disease severity (FEV1 % predicted) F(1,62) = 0.714, P = 0.719 (MANOVA P value is 2-tailed).
*Individual ANOVA P value is one-tailed.
Table 2: Outcome Measures Pre- and Post-Training Comparing UBR-Combined and CE+HE Groups.